Category: Latest News

SAB Biotherapeutics Inc (NASDAQ:SABS) saw its stock surge by 33% following the announcement of a $175 million private placement backed by a mix of strategic and institutional investors. The oversubscribed financing round was led by pharmaceutical giant Sanofi (NASDAQ:SNY) and joined by new investors such as RA Capital Management, Commodore Capital, Vivo Capital, and Blackstone’s…

U.S. stocks moved up slightly on Monday morning as investors looked ahead to a busy week of second-quarter earnings reports, with major firms set to announce results. By 9:35 a.m. ET: Markets had stalled near record highs last Friday amid reports that President Trump is pushing for new tariffs of at least 15% to 20%…

July 21, 2025 — Helius Medical Technologies (NASDAQ:HSDT) saw its stock soar more than 70% in pre-market trading Monday after reporting strong clinical results for its Portable Neuromodulation Stimulator (PoNS) Stroke Registrational Program (SRP). The neurotechnology company announced that a double-blind, randomized clinical trial for the PoNS SRP successfully met its primary endpoint. The trial…

Shares of DeFi Development Corp. (NASDAQ:DFDV) climbed 10.6% after the company revealed it is on the verge of holding 1 million Solana (SOL) tokens, with its balance now totaling 999,999 SOL and equivalents — a position worth approximately $181 million. Between July 14 and July 20, the firm acquired 141,383 SOL at an average cost…

Shares of Upexi Inc. (NASDAQ:UPXI) jumped 14.3% after the company revealed it had expanded its position in Solana, acquiring an additional 100,000 SOL tokens. This latest purchase brings Upexi’s total Solana holdings to 1,818,809 SOL, valued at roughly $331 million. The newly acquired tokens, bought for $17.7 million, follow last week’s closing of a $200…

Shares of SS&C Technologies Holdings Inc (NASDAQ:SSNC) climbed 3.1% after the company announced it has reached a definitive agreement to acquire Calastone, the world’s largest funds network, in a deal valued at roughly £766 million (US $1.03 billion). The seller is global investment firm Carlyle. The acquisition is projected to close in the fourth quarter…

Evotec SE ADR (NASDAQ:EVO) saw its stock decline 12.7% following a downward revision of its revenue guidance for fiscal year 2025, attributed to weaker-than-expected results in its Shared R&D base segment. The company now anticipates revenues between €760 million and €800 million, a reduction from its earlier forecast of €840 million to €880 million. This…

ProMIS Neurosciences Inc. (Nasdaq:PMN), a clinical-stage biotechnology firm specializing in treatments for neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead therapeutic candidate, PMN310, for the treatment of Alzheimer’s disease (AD). PMN310 is a humanized monoclonal antibody designed to selectively target toxic oligomers of…

Bruker Corporation (NASDAQ:BRKR) saw its shares drop 8.75% in premarket trading Monday following the release of preliminary second-quarter figures that showed flat reported revenue and a decline in adjusted earnings. The company cited weak demand from the academic sector and softness in the U.S. biopharma market as key factors behind the results. For the quarter…